Solo-Jec 7 (47P9.22)

Boehringer Ingelheim Vetmedica, Inc

Revision date : 2007-04-06

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating 1
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

54-64-8

Name of the chemical

Sodium o-(ethylmercurithio)benzoate

Concentration

N/A

General Information

Revision date

2007-04-06

Product name

Solo-Jec 7 (47P9.22)

Chemical name

Vaccine

CAS No.

Mixture

1.2.1 Relevant identified uses

Solo-Jec® 7 is recommended for vaccination of healthy, susceptible dogs against disease

Manufacturer Name

Boehringer Ingelheim Vetmedica, Inc

Icons in SDS

Company Information

company name

Boehringer Ingelheim Vetmedica, Inc

GHS Information

Signal word

WARNING!

Section 2

SECTION 2: Hazards identification

OSHA Regulatory Status Emergency Overview Physical State: 1 dose vial of desiccated vaccine cake (canine distemper, canine hepatitis, canine parainfluenza) and 1 mL vial of vaccine diluent (canine parvovirus vaccine-leptospira canicola- icterohaemorrhagiae bacterin). Packages: Single 1 mL dose with a syringe; 25 boxes x 1 mL dose. Color Off white plug and clear liquid. After rehydration tan to yellow liquid Odor: No data available WARNING! For use in dogs only. Not for human use. Severe allergic reactions can occur.

Precautionary statements

Accidental human injection can cause serious local reactions or anaphylactic reaction and systemic effects. Keep only in original container. Keep at a temperature between 2 - 7° C. Fire-fighting: Use foam, carbon dioxide, dry powder and water fog or material appropriate for surrounding fire. Avoid contact with eyes, skin and clothing. Wash thoroughly with soap and water after handling. Wear suitable gloves and eye/face protection. Spills: Cover with absorbent or contain. Collect and dispose. In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible). Have the product container or label with you when calling a poison control center or doctor, or going for treatment. If swallowed, seek medical advice immediately and show this container or label. This material and its container must be disposed of in a safe way. Keep out of reach of children. Keep away from food, drink, and animal feedstuffs. Acute effect: Swelling at injection site may occur. An occasional transitory corneal opacity may occur following administration of the vaccine. This disappears without having an untoward effect on the dog. Precautions/Contraindications: Vaccine may be given subcutaneously or intramuscular. Contains a combination of antigenic, attenuated, strains of Canine Distemper, Parainfluenza, Hepatitis, and Parvovirus propagated in cell line tissue cultures. The diluent is Parvovirus Vaccine-Leptospira canicola-icterohaemorrhagiae bacterin. The infectious Canine Hepatitis (CAV-1) fraction cross protects against respiratory disease caused by CAV-2. Do not vaccinate pregnant animals. Do not use in ferrets or mink. Protective immunity may not be completely established in all puppies vaccinated at less than 16 weeks of age because of maternal antibody interference. Only vaccinate healthy animals. Animals incubating any disease or stressed due to shipping, malnutrition, or parasitism may not achieve or maintain an adequate immune response. Use entire contents when first opened. Overdosage: None known. ADVERSE REACTIONS TO PRODUCT: Anaphylactoid reactions may occur but are rare.

Potential health effects

Inhalation: Not expected to be an inhalation hazard with prescribed use. Eye Contact: Not expected to be a hazard to the eye with prescribed use. Exposure to liquid in eye may cause mild eye irritation. Skin Contact: Not expected to be a hazard to the skin. Can cause hypersensitive reactions. May cause skin sensitization by contact. Ingestion: Not expected to be an ingestion hazard with prescribed use. Ingestion may cause nausea and systemic effects. Injection: Swelling at injection site may occur.

Potential chronic health

Possible hypersensitization (development of abnormal sensitivity) Target Organ(s): Immune System Potential Physical Effects: Can cause skin sensitization. OSHA Regulatory Status: Nonhazardous, exempt

Environmental hazards

No data available

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.